Evidence map›Paper›PMID 41393622›Full record

ArticleCureus2025

Autoimmune Disease Flare-Up in a Case of Locally Advanced Breast Carcinoma Controlled by Surgical Resection.

Ilango Parthasarathy, Gowtham Karthik V, Syed A Hussain

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ilango ParthasarathySurgical Oncology, Sri Ramachandra Institute of Higher Education and Research, Chennai, IND.
Gowtham Karthik VSurgical Oncology, Sri Ramachandra Institute of Higher Education and Research, Chennai, IND.
Syed A HussainSurgical Oncology, Sri Ramachandra Institute of Higher Education and Research, Chennai, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autoimmune diseases and malignancies share complex immunological interactions, but their coexistence in a single patient presents unique diagnostic and therapeutic challenges. We report the case of a 65-year-old woman with a history of autoimmune disease who presented with a locally advanced carcinoma of the breast. Despite ongoing immunosuppressive therapy, she developed a flare of autoimmune manifestations during the progression of her malignancy. The patient underwent surgical resection of the primary tumor, which not only achieved local oncological control but also resulted in a marked improvement of her autoimmune symptoms postoperatively. This case highlights the dual nature of the immune system in cancer, where immune dysregulation contributes both to tumor progression and to autoimmunity. The clinical course of our patient suggests that tumor antigens may serve as a chronic stimulus for immune activation, thereby exacerbating autoimmune flares. Surgical resection eliminated the source of antigenic stimulation, leading to symptom resolution, underscoring the potential therapeutic role of surgery beyond oncological benefit. Recognition of autoimmune disease exacerbations as a manifestation of underlying malignancy is crucial, as they may mimic paraneoplastic syndromes and delay appropriate treatment. A multidisciplinary approach involving oncologists, surgeons, and rheumatologists is essential for optimal care in such complex cases. This report adds to the limited literature on autoimmune disease flares associated with breast carcinoma and suggests that timely surgical intervention can achieve disease control on two fronts, cancer progression and immune dysregulation.

Indexed as

autoimmune diseasebreast carcinomaductal carcinoma immunomodulationinvasive paraneoplastic syndromelupus erythematosusreactive oxygen species (ros)regulatory t cells (tregs)surgical resectiontumor microenvironment

Identifiers

PMID41393622
PMCPMC12696681

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.